Chembio Diagnostics, Inc. (CEMI) SEC Filing 8-K Material Event for the period ending Wednesday, February 27, 2019

Chembio Diagnostics, Inc.

CIK: 1092662 Ticker: CEMI

View differences made from one to another to evaluate Chembio Diagnostics, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Chembio Diagnostics, Inc..


Assess how Chembio Diagnostics, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Chembio Diagnostics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Chembio Diagnostics, Inc. provided additional information to their SEC Filing as exhibits

Ticker: CEMI
CIK: 1092662
Form Type: 8-K Corporate News
Accession Number: 0001140361-19-004442
Submitted to the SEC: Tue Mar 05 2019 5:00:11 PM EST
Accepted by the SEC: Tue Mar 05 2019
Period: Wednesday, February 27, 2019
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. New Agreement
  3. New Financial Obligation

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: